PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFolinoral
Folinoral
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1243 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD01517978262144519467
AdenocarcinomaD000230421053818175
Pancreatic neoplasmsD010190EFO_0003860C2551943016159
NeoplasmsD009369C8067652313140
Stomach neoplasmsD013274EFO_0003897C1623641917103
Esophageal neoplasmsD004938C151848101370
Neoplasm metastasisD009362EFO_00097081237201466
Liver neoplasmsD008113EFO_1001513C22.0725131545
CholangiocarcinomaD018281C22.14132119
Non-small-cell lung carcinomaD002289104213
Show 7 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rectal neoplasmsD012004215425599
Colonic neoplasmsD003110C18173437785
CarcinomaD002277C80.0234223684
LeukemiaD007938C95164229483
LymphomaD008223C85.9144119673
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.0103128365
Lymphoid leukemiaD007945C91102825359
RecurrenceD01200815237143
Hepatocellular carcinomaD006528C22.03198330
Pancreatic ductal carcinomaD02144111175130
Show 86 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Renal cell carcinomaD002292EFO_00003769713
Myelodysplastic syndromesD009190D468310
PreleukemiaD0112898310
Ovarian neoplasmsD010051EFO_0003893C564610
SarcomaD012509369
OsteosarcomaD0125164519
Breast neoplasmsD001943EFO_0003869C50448
Digestive system neoplasmsD004067648
ArthritisD001168EFO_0005856M05-M142618
Myeloid leukemia acuteD015470C92.0717
Show 107 more
Indications Phases 1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acquired immunodeficiency syndromeD000163EFO_0000765B2022
AggressionD000374EFO_000301511
Invasive hydatidiform moleD002820D39.211
Juvenile arthritisD001171EFO_1002007M0811
Pseudomyxoma peritoneiD011553EFO_000745611
Vascular system injuriesD057772T14.811
MicrobiotaD06430711
Immunologic deficiency syndromesD007153D84.911
Healthy dietD00007200111
Ultrasonic therapyD01446411
Show 7 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
88 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use